Annual Shareholders Equity
$130.19 M
-$104.95 M-44.63%
31 December 2023
Summary:
Athira Pharma annual stockholders equity is currently $130.19 million, with the most recent change of -$104.95 million (-44.63%) on 31 December 2023. During the last 3 years, it has fallen by -$144.09 million (-52.53%). ATHA annual shareholders equity is now -59.45% below its all-time high of $321.08 million, reached on 31 December 2021.ATHA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$57.58 M
-$25.75 M-30.90%
30 September 2024
Summary:
Athira Pharma quarterly stockholders equity is currently $57.58 million, with the most recent change of -$25.75 million (-30.90%) on 30 September 2024. Over the past year, it has dropped by -$97.18 million (-62.79%). ATHA quarterly shareholders equity is now -84.15% below its all-time high of $363.22 million, reached on 31 March 2021.ATHA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.6% | -62.8% |
| 3 y3 years | -52.5% | -82.9% |
| 5 y5 years | +974.5% | - |
ATHA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.5% | at low | -82.9% | at low |
| 5 y | 5 years | -59.5% | +760.1% | -84.2% | +392.0% |
| alltime | all time | -59.5% | +760.1% | -84.2% | +392.0% |
Athira Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $57.58 M(-30.9%) |
| June 2024 | - | $83.33 M(-21.9%) |
| Mar 2024 | - | $106.74 M(-18.0%) |
| Dec 2023 | $130.19 M(-44.6%) | $130.19 M(-15.9%) |
| Sept 2023 | - | $154.76 M(-16.3%) |
| June 2023 | - | $184.98 M(-12.4%) |
| Mar 2023 | - | $211.13 M(-10.2%) |
| Dec 2022 | $235.14 M | $235.14 M(-10.3%) |
| Sept 2022 | - | $262.25 M(-6.5%) |
| June 2022 | - | $280.56 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $301.98 M(-6.0%) |
| Dec 2021 | $321.08 M(+17.1%) | $321.08 M(-4.5%) |
| Sept 2021 | - | $336.24 M(-4.1%) |
| June 2021 | - | $350.71 M(-3.4%) |
| Mar 2021 | - | $363.22 M(+32.4%) |
| Dec 2020 | $274.28 M(-1490.7%) | $274.28 M(+5.7%) |
| Sept 2020 | - | $259.47 M(+224.7%) |
| June 2020 | - | $79.92 M(-505.2%) |
| Dec 2019 | -$19.72 M(+32.5%) | -$19.72 M |
| Dec 2018 | -$14.89 M | - |
FAQ
- What is Athira Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Athira Pharma?
- What is Athira Pharma annual shareholders equity year-on-year change?
- What is Athira Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Athira Pharma?
- What is Athira Pharma quarterly shareholders equity year-on-year change?
What is Athira Pharma annual stockholders equity?
The current annual shareholders equity of ATHA is $130.19 M
What is the all time high annual shareholders equity for Athira Pharma?
Athira Pharma all-time high annual stockholders equity is $321.08 M
What is Athira Pharma annual shareholders equity year-on-year change?
Over the past year, ATHA annual stockholders equity has changed by -$104.95 M (-44.63%)
What is Athira Pharma quarterly stockholders equity?
The current quarterly shareholders equity of ATHA is $57.58 M
What is the all time high quarterly shareholders equity for Athira Pharma?
Athira Pharma all-time high quarterly stockholders equity is $363.22 M
What is Athira Pharma quarterly shareholders equity year-on-year change?
Over the past year, ATHA quarterly stockholders equity has changed by -$97.18 M (-62.79%)